CAM
Cresset Asset Management Portfolio holdings
AUM
$23.1B
1-Year Return
20.55%
This Quarter Return
-3.94%
1 Year Return
+20.55%
3 Year Return
+73.62%
5 Year Return
+131.25%
10 Year Return
–
AUM
$9.62B
AUM Growth
-$744M
(-7.2%)
Cap. Flow
-$251M
Cap. Flow
% of AUM
-2.61%
Top 10 Holdings %
Top 10 Hldgs %
62.5%
Holding
1,202
New
82
Increased
256
Reduced
580
Closed
220
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$151M |
| 2 |
iShares Gold Trust
IAU
|
+$63.4M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$42.9M |
| 4 |
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
|
+$24.2M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$12.3M |
Top Sells
| 1 |
Apple
AAPL
|
+$92.8M |
| 2 |
Hyatt Hotels
H
|
+$53.4M |
| 3 |
ARK Innovation ETF
ARKK
|
+$23.3M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$17.2M |
| 5 |
Microsoft
MSFT
|
+$16.6M |
Sector Composition
| 1 | Technology | 35.58% |
| 2 | Consumer Discretionary | 4.69% |
| 3 | Financials | 2.77% |
| 4 | Healthcare | 2.45% |
| 5 | Communication Services | 1.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Ventas
VTR
$31B
| $513K | 0.01% |
8,254
+2,205
| +36% | +$137K |
|
|
BHVN
602
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $511K | 0.01% |
4,305
-787
| -15% | -$93.4K |
|
603
LKQ Corp
LKQ
$8.31B
| $510K | 0.01% |
11,246
+143
| +1% | +$6.49K |
|
604
iShares Morningstar Mid-Cap Growth ETF
IMCG
$2.92B
| $509K | 0.01% |
7,914
| – | – |
|
605
Doximity
DOCS
$13B
| $508K | 0.01% |
9,754
-282
| -3% | -$14.7K |
|
|
ANSS
606
DELISTED
Ansys
ANSS
| $506K | 0.01% |
1,591
-733
| -32% | -$233K |
|
607
Boston Scientific
BSX
$160B
| $501K | 0.01% |
11,317
+2,268
| +25% | +$100K |
|
608
IQVIA
IQV
$32.2B
| $499K | 0.01% |
2,157
-385
| -15% | -$89.1K |
|
609
TransDigm Group
TDG
$73.9B
| $496K | 0.01% |
762
-8
| -1% | -$5.21K |
|
610
Dolby
DLB
$6.93B
| $495K | 0.01% |
6,332
+172
| +3% | +$13.4K |
|
|
AFAQU
611
DELISTED
AF Acquisition Corp. Units
AFAQU
| $492K | 0.01% |
50,000
-25,000
| -33% | -$246K |
|
|
OSH
612
DELISTED
Oak Street Health, Inc.
OSH
| $491K | 0.01% |
18,286
-6,218
| -25% | -$167K |
|
613
Organon & Co
OGN
$2.7B
| $488K | 0.01% |
13,969
+493
| +4% | +$17.2K |
|
614
Schwab US Large-Cap Growth ETF
SCHG
$49B
| $487K | 0.01% |
+26,040
| New | +$487K |
|
615
Humana
HUM
$32.8B
| $486K | 0.01% |
1,115
-144
| -11% | -$62.8K |
|
616
Welltower
WELL
$113B
| $485K | 0.01% |
5,044
+125
| +3% | +$12K |
|
617
Alignment Healthcare
ALHC
$3.26B
| $484K | 0.01% |
43,074
| – | – |
|
618
SPDR S&P Emerging Markets Small Cap ETF
EWX
$723M
| $481K | 0.01% |
8,499
+2,387
| +39% | +$135K |
|
619
Iovance Biotherapeutics
IOVA
$858M
| $479K | 0.01% |
28,794
+9,407
| +49% | +$156K |
|
620
Virgin Galactic
SPCE
$183M
| $479K | 0.01% |
2,421
-295
| -11% | -$58.4K |
|
621
Eagle Bancorp
EGBN
$592M
| $478K | 0.01% |
8,384
-7
| -0.1% | -$399 |
|
622
Match Group
MTCH
$9.19B
| $477K | 0.01% |
4,384
+1,486
| +51% | +$162K |
|
623
DTE Energy
DTE
$28B
| $475K | ﹤0.01% |
3,565
-6,214
| -64% | -$828K |
|
624
Diageo
DEO
$58.3B
| $471K | ﹤0.01% |
2,303
-336
| -13% | -$68.7K |
|
625
State Street
STT
$31.8B
| $467K | ﹤0.01% |
5,325
-316
| -6% | -$27.7K |
|